CLINICAL TRIALS PROFILE FOR DESOGESTREL AND ETHINYL ESTRADIOL
✉ Email this page to a colleague
All Clinical Trials for DESOGESTREL AND ETHINYL ESTRADIOL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00204438 ↗ | Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle | Completed | Canadian Institutes of Health Research (CIHR) | N/A | 2002-02-01 | We hypothesize that administration of OCs at varying follicular diameters will provide an appropriate model for the study of follicular atresia in women. Clinically, we hypothesize that the administration on OCs at different stages of the follicular phase will result in markedly different patterns of follicular development and/or atresia. |
| NCT00204438 ↗ | Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle | Completed | University of Saskatchewan | N/A | 2002-02-01 | We hypothesize that administration of OCs at varying follicular diameters will provide an appropriate model for the study of follicular atresia in women. Clinically, we hypothesize that the administration on OCs at different stages of the follicular phase will result in markedly different patterns of follicular development and/or atresia. |
| NCT00439972 ↗ | Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity | Unknown status | Ortho-McNeil Pharmaceutical | Phase 2 | 2007-02-01 | The purpose of this study is to compare the effects of oral versus patch administration of hormonal contraception on hormone sensitive proteins such as lipoproteins, clotting factors and inflammatory proteins as well as blood sugar and insulin levels, antioxidant status and flow-mediated dilation of arm and forearm vessels. The hypothesis is that oral administration of contraceptive hormones will result in higher plasma levels of estrogen sensitive proteins originating from the liver while patch administration of contraceptive hormones will result in greater systemic effects of estrogen on vascular reactivity and antioxidant status. |
| NCT00439972 ↗ | Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity | Unknown status | University of Washington | Phase 2 | 2007-02-01 | The purpose of this study is to compare the effects of oral versus patch administration of hormonal contraception on hormone sensitive proteins such as lipoproteins, clotting factors and inflammatory proteins as well as blood sugar and insulin levels, antioxidant status and flow-mediated dilation of arm and forearm vessels. The hypothesis is that oral administration of contraceptive hormones will result in higher plasma levels of estrogen sensitive proteins originating from the liver while patch administration of contraceptive hormones will result in greater systemic effects of estrogen on vascular reactivity and antioxidant status. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DESOGESTREL AND ETHINYL ESTRADIOL
Condition Name
Clinical Trial Locations for DESOGESTREL AND ETHINYL ESTRADIOL
Trials by Country
Clinical Trial Progress for DESOGESTREL AND ETHINYL ESTRADIOL
Clinical Trial Phase
Clinical Trial Sponsors for DESOGESTREL AND ETHINYL ESTRADIOL
Sponsor Name
